Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Syneos Health Launches Lab to Life Enterprise Partnership with Komodo Health

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Penumbra Wins CE Mark for Thunderbolt...

Penumbra announced that it has secured CE mark approval...

Kaopiz Holdings, QuantumTX Partner on AI...

In a significant move toward transforming the healthcare sector,...

New InterSystems TrakCare Community Solution Goes...

Leading community health service codesigns Australian solution to improve...

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced it has expanded its relationship with Komodo Health, a data-driven healthcare software company with access to the broadest array of real-world data across patients and practitioners. The partnership will allow Syneos Health to better analyze clinical, real-world, and commercial data, offering customers a seamless integration to their operational trial designs and commercialization deployment strategies to transform biopharmaceutical product development.

Powered by Komodoโ€™s Healthcare Mapโ„ข, the new solution integrates Komodo Healthโ€™s Prism and Sentinel applications to better enable Syneos Health to perform sophisticated studies, analyzing comprehensive and de-identified, aggregated patient data. The resulting insights inform clinical trial design and delivery and generate real-world evidence on product effectiveness, safety and utilization in the healthcare system. These differentiated insights across a wide range of use cases in real-world evidence and late phase studies will accelerate clinical development and commercialization.

The expanded partnership builds on two-years of previous collaboration between Syneos Health and Komodo Health, which began with data-driven strategies to enhance customer engagement for the Syneos Health Kineticโ„ข team.

โ€œBiopharma companies are transforming to meet the challenges of a more complex operating, regulatory, and reimbursement environment,โ€ said Larry Pickett, Chief Information and Digital Officer, for Syneos Health. โ€œKomodo is an important foundational platform to our Dynamic Assemblyยฎ network, our flexible data and technology strategy that optimizes opportunities for customers and helps increase the likelihood of regulatory approval and commercial success. Our expanded relationship with Komodo Health allows Syneos Health to better integrate our clinical, real-world and late phase data and commercial capabilities to deliver on the entire spectrum of Lab to Life product development.โ€

Komodo Healthโ€™s Platform and suite of applications will be an important part of the Syneos Health Dynamic Assembly network, an open ecosystem of preferred, best-of-breed data and technology collaborators committed to delivering fit-for-purpose solutions designed to strategically address the nuances of each customer engagement.

Syneos Health will leverage Komodo Healthโ€™s Prism software to support feasibility, market sizing, site selection and patient cohort analytics. Additionally, Komodoโ€™s Sentinel solution will provide a comprehensive view into real-world patient journeys and enable the integration of proprietary datasets, tools and algorithms to derive best-in-class insight. These data-native solutions, built on Komodoโ€™s Healthcare Map of 325 million de-identified patient journeys in the U.S., will play an important role for Syneos Health in matching site activation and patient enrollment for clinical trials, highly tailored to patient proximity hotspots to optimize clinical trial operational strategies.

โ€œFrom cardiovascular health to ultra-rare diseases, Syneos Health is now poised to capitalize on a new generation of data-driven intelligence, built on a foundation of patient-level data that is unparalleled in the industry,โ€ said Web Sun, Co-founder and President, for Komodo Health. โ€œThrough our Prism and Sentinel solutions, Komodo is proud to deploy our unique software capabilities to fuel Syneos Healthโ€™s real-world evidence capabilities and growth as they continue to provide differentiated insights for their clients.โ€

About Syneos Health

Syneos Health is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 25,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customersโ€™ delivery of important therapies to patients.

About Komodo

Komodo Health believes that smarter, more innovative use of data and analytics is essential for reducing disease burden. We apply artificial intelligence and other advanced data science techniques to our first-of-its-kind Healthcare Mapโ„ข, which tracks the unique patient journeys of over 325 million patients. We empower a multitude of healthcare stakeholders โ€“ life science companies, healthcare payers and providers, patient advocacy groups, and others โ€“ to create a more cost-effective, value-driven healthcare system.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Penumbra Wins CE Mark for Thunderbolt Thrombectomy System

Penumbra announced that it has secured CE mark approval...

Kaopiz Holdings, QuantumTX Partner on AI Healthcare Solution

In a significant move toward transforming the healthcare sector,...

New InterSystems TrakCare Community Solution Goes Live at Gateway Health

Leading community health service codesigns Australian solution to improve...

ResMed Completes $340 Million Acquisition of Noctrix Health

Global sleep and breathing health company ResMed has finalized...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป